Description: This background paper is the second in a series of OTA studies being carried out under an assessment of “New Developments in Biotechnology. ” Volume one in the series examined commercialization and ownership of human tissues and cells, and forthcoming reports will include evaluations of: U.S. investment in biotechnology; genetically engineered organisms in the environment; tests for human genetic disorders; and the impact of intellectual property law on biotechnology. The assessment was requested by the House Committee on Science, Space, and Technology and the House Committee on Energy and Commerce.
Date: May 1987
Creator: United States. Congress. Office of Technology Assessment.
Partner: UNT Libraries Government Documents Department